A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2011
12/22/2011	CA2802376A1 Anti-vegf antibodies and uses thereof
12/22/2011	CA2802351A1 Clostridium taeniosporum spores and spore appendages as surface display hosts, drug delivery devices, and nanobiotechnological structures
12/22/2011	CA2802349A1 Anti-dr4 agonist antibodies
12/22/2011	CA2802344A1 Bi-specific antibodies against tim-3 and pd-1 for immunotherapy in chronic immune conditions
12/22/2011	CA2801210A1 Anti-gd2 antibodies
12/22/2011	CA2800757A1 Stabilised human immunoglobulin composition
12/22/2011	CA2797926A1 Anti-human equilibrative nucleoside transporter 1 (hent1) antibodies and methods of use thereof
12/22/2011	CA2794731A1 Anti-axl antibodies and methods of use
12/21/2011	EP2397555A1 Fusion proteins of mycobacterium tuberculosis antigens and their uses
12/21/2011	EP2397553A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
12/21/2011	EP2397552A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
12/21/2011	EP2397549A2 Non-stochastic generation of genetic vaccines and enzymes
12/21/2011	EP2397547A1 Drug transporter, and adjuvant and vaccine each utilizing same
12/21/2011	EP2397542A1 Modified parvovirus having enhanced anti-tumour efficacy
12/21/2011	EP2397500A1 Monoclonal antibody SC104 and derivative thereof specifically binding to a sialyltetraosyl carbohydrate as a potential anti-tumor therapeutic agent
12/21/2011	EP2397499A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397498A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397497A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397496A2 Human anti-B7RP1 neutralizing antibodies
12/21/2011	EP2397494A1 Human antibodies that bind human TNFalpha
12/21/2011	EP2397490A1 Vaccine constructs and combinations of vaccines designed to improve the breadth of the immune response to diverse strains and clades of HIV
12/21/2011	EP2397484A1 Trisaccharide derivates, and their use as adjuvants
12/21/2011	EP2397189A1 Methods of modulating immunity
12/21/2011	EP2397156A1 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1)pathway
12/21/2011	EP2397155A1 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1)pathway
12/21/2011	EP2397154A2 Peptides for desensibilization against allergens
12/21/2011	EP2397153A1 Novel composition
12/21/2011	EP2396409A2 Synthetic rna-based agonists of tlr7
12/21/2011	EP2396348A1 Methods for inducing transplantation tolerance
12/21/2011	EP2396084A1 Anti-mst1r antibodies and uses thereof
12/21/2011	EP2396035A2 Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
12/21/2011	EP2396034A1 Antibodies and methods for treating estrogen receptor-associated diseases
12/21/2011	EP2396033A2 Influenza hemagglutinin and neuraminidase variants
12/21/2011	EP2396032A2 Influenza vaccines with reduced amounts of squalene
12/21/2011	EP2396031A1 Influenza vaccines with increased amounts of h3 antigen
12/21/2011	EP2396030A1 Influenza vaccine regimens for pandemic-associated strains
12/21/2011	EP2396029A1 Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
12/21/2011	EP2396021A2 Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22
12/21/2011	EP2395992A2 Chemically programmed vaccination
12/21/2011	EP2136837B1 Oil-in-water emulsion influenza vaccine
12/21/2011	EP2012123B1 Marker for predicting graft-versus-host disease and utilization of the same
12/21/2011	EP1928418B1 Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
12/21/2011	EP1524995B1 Co-administration of cg250 and il-2 or ifn-alpha for treating cancer such as renal cell carcinomas
12/21/2011	EP1461078B1 A PEPTIDE-BASED FLUORESCENCE POLARIZATION ASSAY FOR DETECTION OF ANTIBODIES TO i MYCOBACTERIUM BOVIS /i
12/21/2011	EP1454142B1 Inhibition of tristetraproline for protection of the heart from cardiac injuries
12/21/2011	EP1414848B1 Replikin peptides and uses thereof
12/21/2011	EP1386152B1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
12/21/2011	EP1266003B1 Kcnb: a potassium channel protein
12/21/2011	CN1990043B 重组人粒细胞巨噬细胞集落刺激因子在制备治疗或预防乙型肝炎药物中的用途 Recombinant human granulocyte-macrophage colony-stimulating factor in the preparation of a medicament for the treatment or prevention of hepatitis B
12/21/2011	CN1732017B 用于治疗瘤形成的生长调节因子和激素的组合 For the treatment of neoplasia growth regulating composition factors and hormones
12/21/2011	CN1650013B 抗汉坦病毒属病毒感染的dna疫苗 Anti-hantavirus infection dna vaccine
12/21/2011	CN102292449A 预防或治疗血栓形成的il-6拮抗剂 Prevention or treatment of thrombosis il-6 antagonist
12/21/2011	CN102292432A 鸡败血支原体制剂 Mycoplasma gallisepticum preparations
12/21/2011	CN102292353A 用于治疗ige介导的疾患的新组合物和方法 The new combination therapy ige-mediated disorders and methods for
12/21/2011	CN102292350A 对来自甲型流感病毒血凝素的融合肽特异的单克隆抗体及其用途 Of hemagglutinin from the influenza virus fusion peptide specific monoclonal antibodies and uses thereof
12/21/2011	CN102292107A 增加白蛋白和/或减少crp的il-6拮抗剂 Increase in albumin and / or reduce the il-6 antagonist crp
12/21/2011	CN102292106A Il-6抗体及其用途 Il-6 antibody and uses thereof
12/21/2011	CN102292105A 用于诱导抗金黄色葡萄球菌的保护性免疫应答的多肽 Peptides induce protection against S. aureus immune response to
12/21/2011	CN102292104A 用于诱导抗金黄色葡萄球菌的保护性免疫应答的多肽 Peptides induce protection against S. aureus immune response to
12/21/2011	CN102292103A 纯化疟原虫(plasmodium)和疫苗组合物 Purification of Plasmodium (plasmodium) and vaccine compositions
12/21/2011	CN102292102A 免疫应答的引发 Eliciting an immune response
12/21/2011	CN102286408A 一种解淀粉芽胞杆菌wh3及制备方法和用途 A Solution starch Bacillus wh3 and preparation and use
12/21/2011	CN102286391A 水貂出血性肺炎二价灭活疫苗及其制备方法 Mink hemorrhagic pneumonia bivalent inactivated vaccine and its preparation method
12/21/2011	CN102286107A 一种高效表达重组丙型肝炎病毒多表位抗原的方法和应用 An efficient expression of recombinant hepatitis C virus multi-epitope approach and application
12/21/2011	CN102286106A 夹心外膜蛋白展示载体及应用其制备的大肠埃希菌疫苗 Sandwich outer membrane protein of Escherichia coli display vector vaccine preparation and application of
12/21/2011	CN102286104A Hpv6型l2n120e7e6融合蛋白基因、表达载体、方法、菌株和用途 Hpv6 type l2n120e7e6 fusion protein gene, expression vectors, methods, and uses of the strain
12/21/2011	CN102286102A 钠钾atp酶dr区特异性抗体制备方法及其治疗肾脏缺血再灌注损伤中的药物作用 Sodium and potassium atp enzyme dr district drug-specific antibodies preparation and treatment of renal ischemia-reperfusion injury
12/21/2011	CN102286101A 抗VEGF单克隆抗体Fab片段Vasculizumab及其应用 Anti-VEGF monoclonal antibody Fab fragments and its application Vasculizumab
12/21/2011	CN102286099A 静注巨细胞病毒人免疫球蛋白及其制备方法 Intravenous immune globulin human cytomegalovirus and its preparation method
12/21/2011	CN102286083A 分泌型肺炎链球菌蛋白质 Secreted proteins of Streptococcus pneumoniae
12/21/2011	CN102286077A T细胞表位肽 T cell epitope peptide
12/21/2011	CN102286075A 乙肝病毒表面抗原的免疫显性hla-a1101限制性ctl表位及其应用 Hepatitis B virus surface antigen immunodominant hla-a 1101 restricted epitopes ctl its application
12/21/2011	CN102286068A 一种狂犬病毒疫苗增效蛋白及编码该蛋白的基因和应用 One kind of synergistic rabies virus vaccine protein and the gene encoding the protein and applications
12/21/2011	CN102284065A 壳聚糖猪流感dna疫苗纳米粒的制备方法 Preparation of chitosan nanoparticles swine flu vaccine dna
12/21/2011	CN102284061A 一种耐热型家畜用疫苗的制备方法 A heat-resistant livestock vaccine preparation
12/21/2011	CN102284058A 复制缺陷型抗ev71和ca16病毒双价疫苗的制备方法 Replication-defective anti ev71 and preparation methods ca16 bivalent vaccine virus
12/21/2011	CN101935637B Recombinant low-virulent vaccine strain of chicken infectious bursal disease viruses (IBDV) and application thereof
12/21/2011	CN101843900B 一种禽流感灭活疫苗及其制造方法 An inactivated avian influenza vaccine and its manufacturing method
12/21/2011	CN101623268B 一种血管内皮生长因子单克隆抗体Avastin壳聚糖纳米粒制剂 One kind of vascular endothelial growth factor monoclonal antibody Avastin chitosan nanoparticles formulation
12/21/2011	CN101597327B 一种o型口蹄疫病毒抗原表位的分子模拟肽及其用途 One kind o-mouth disease virus epitope peptide molecular modeling and their use
12/21/2011	CN101565465B 一种抗刚地弓形虫表面抗原1人源抗体Fab片段及其编码基因 An anti-Toxoplasma gondii surface antigen a human antibody Fab fragments and coding gene
12/21/2011	CN101432017B 用于诱导针对金黄色葡萄球菌的保护性免疫应答的多肽 Polypeptides protective against S. aureus for inducing an immune response
12/21/2011	CN101277718B 作为长效止痛剂的能抑制NGF与TrkA受体的结合的分子 As can inhibit the binding of NGF and TrkA receptor molecules of long-acting analgesics
12/21/2011	CN101252951B 抗il-23抗体、组合物、方法和用途 Anti-il-23 antibodies, compositions, methods and uses
12/21/2011	CN101244267B 一种增强微生物疫苗免疫原性的免疫制剂 An enhanced microbial vaccine immunogenicity immune agents
12/20/2011	US8080642 Severe acute respiratory syndrome DNA compositions and methods of use
12/20/2011	US8080639 Antibodies which bind specifically to activin receptor like kinase 3
12/20/2011	US8080638 Anti-interferon alpha monoclonal antibodies and methods for use
12/20/2011	US8080636 BSL3 antibodies
12/20/2011	US8080635 Non-functional P2X7 receptor
12/20/2011	US8080633 Antiviral compositions comprising a multiple branched peptide construct containing human CD38 leukocyte surface antigen polypeptides
12/20/2011	US8080554 Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
12/20/2011	US8080534 Targeting PAX2 for the treatment of breast cancer
12/20/2011	US8080525 Peptide compositions and their use against the hepatitis C virus
12/20/2011	US8080431 Nanoparticles
12/20/2011	US8080388 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
12/20/2011	US8080369 Methods for activating peripheral blood mononuclear cells (PBMCs) by administering human immunodeficiency virus (HIV) Tat under physiological oxygen levels
12/20/2011	US8080256 Endophytic fungi from Pteromischum sp. plant, compounds and methods of use
12/20/2011	US8080255 Functional influenza virus like particles (VLPs)
12/20/2011	US8080254 OB fusion protein compositions and methods

1 ... 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 ... 1823